The California Stem Cell Report
Subscribe
Sign in
Home
sustainability
cirm future
CIRM's $3.9 Billion Priority …
A CIRM Primer -- A to Z
CIRM Sustainability
Leaderboard
About
cirm future
Latest
Top
Discussions
Waning Financial Enthusiasm for Gene Therapies: National Picture is Bleak, Says Barron's
California multibillion-dollar program scheduled to discuss its research portfolio next week
Jun 19
•
David Jensen
1
Share this post
The California Stem Cell Report
Waning Financial Enthusiasm for Gene Therapies: National Picture is Bleak, Says Barron's
Copy link
Facebook
Email
Notes
More
Fertile Field for California's Stem Cell/Gene Therapy Story: Can It Measure Up?
National turmoil over research in sharp contrast to operations of California Institute for Regenerative Medicine
May 8
•
David Jensen
1
Share this post
The California Stem Cell Report
Fertile Field for California's Stem Cell/Gene Therapy Story: Can It Measure Up?
Copy link
Facebook
Email
Notes
More
From Market Studies to 'Value' Messaging, California Stem Cell/Gene Therapy Agency Bets Big on Affordability Plan
Far-reaching effort to ensure that revolutionary treatments reach all patients
May 1
•
David Jensen
3
Share this post
The California Stem Cell Report
From Market Studies to 'Value' Messaging, California Stem Cell/Gene Therapy Agency Bets Big on Affordability Plan
Copy link
Facebook
Email
Notes
More
California's Affordability Plan for Cell/Gene Therapy Could be National Model
CIRM proposal nears launch in two clinical award rounds totaling $295 million
Apr 28
•
David Jensen
Share this post
The California Stem Cell Report
California's Affordability Plan for Cell/Gene Therapy Could be National Model
Copy link
Facebook
Email
Notes
More
California's Pathway to the Affordability of Multimillion-Dollar, Revolutionary Stem Cell and Gene Therapies
The effort by CIRM was mandated by voters four years ago.
Apr 25
•
David Jensen
1
Share this post
The California Stem Cell Report
California's Pathway to the Affordability of Multimillion-Dollar, Revolutionary Stem Cell and Gene Therapies
Copy link
Facebook
Email
Notes
More
A Life and Death Matter? The Frustrating 'Non-Image' of California's $12 Billion Gene Therapy/Stem Cell Research Program
CIRM directors tackle its financial sustainability, first time since 2017
Apr 21
•
David Jensen
Share this post
The California Stem Cell Report
A Life and Death Matter? The Frustrating 'Non-Image' of California's $12 Billion Gene Therapy/Stem Cell Research Program
Copy link
Facebook
Email
Notes
More
California's Stem Cell/Gene Therapy Agency, a Man Named Marks and the Future
His departure unsettles biomedical world and investors
Mar 31
•
David Jensen
4
Share this post
The California Stem Cell Report
California's Stem Cell/Gene Therapy Agency, a Man Named Marks and the Future
Copy link
Facebook
Email
Notes
More
2
Tracking the Wild CIRM: Sweeping Overviews of the Stem Cell/Gene Therapy Agency Are Upcoming
You can comment at the meetings or in writing ahead of the sessions
Dec 11, 2024
•
David Jensen
2
Share this post
The California Stem Cell Report
Tracking the Wild CIRM: Sweeping Overviews of the Stem Cell/Gene Therapy Agency Are Upcoming
Copy link
Facebook
Email
Notes
More
20th Anniversary of California's $12 Billion Stem Cell Program: Kudos and Criticism
CIRM launching new efforts to boost its impact, affordability of new therapies
Dec 5, 2024
•
David Jensen
2
Share this post
The California Stem Cell Report
20th Anniversary of California's $12 Billion Stem Cell Program: Kudos and Criticism
Copy link
Facebook
Email
Notes
More
CIRM's 'Daring,' $26 Million Bet on a Treatment for a Deadly Muscular Disease
Capricor and Cedars-Sinai researchers involved
Nov 5, 2024
•
David Jensen
1
Share this post
The California Stem Cell Report
CIRM's 'Daring,' $26 Million Bet on a Treatment for a Deadly Muscular Disease
Copy link
Facebook
Email
Notes
More
California is Building a New Path to Rare Disease Cures; First Target is Neuro Afflictions
Fresh details unveiled last week by CIRM
Oct 29, 2024
•
David Jensen
Share this post
The California Stem Cell Report
California is Building a New Path to Rare Disease Cures; First Target is Neuro Afflictions
Copy link
Facebook
Email
Notes
More
Six Month Pause on Research Applications at California's Stem Cell and Gene Therapy Program
Multibillion-dollar enterprise needs time to work through its sweeping, new priorities
Oct 4, 2024
•
David Jensen
2
Share this post
The California Stem Cell Report
Six Month Pause on Research Applications at California's Stem Cell and Gene Therapy Program
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts